Amperos Health, a provider of an AI-native denial management and revenue recovery platform for healthcare providers, raised $16 million in a Series A funding round, led by Bessemer Venture Partners, with participation from Uncork Capital and Neo.
Including the latest Series A round, Amperos Health has raised $20.2 million in disclosed funding to date. The startup earlier secured a $4.2 million seed funding round in June 2025.
With fresh funds, Amperos Health accelerates the rollout of its HIPAA-compliant, AI-powered denial management and revenue recovery solution designed specifically for healthcare providers to combat denials and streamline claims collections for revenue cycle management (RCM) teams.
According to data provided by Amperos Health, to date, its platform has served over 3,000 clinical locations across all 50 states, driving nearly $700 million of revenue recovered per year across over 500,000 claims.
Denials are rising in healthcare today, with 12% of claims denied in 2024, representing a $262 billion loss in revenue to providers. Providers then spend more than $26 billion annually in recovering these denied claims, of which 70% end up getting paid. And yet, 63% of RCM teams are understaffed, while healthcare administration teams face a 32% annual turnover rate.
“Our mission at Amperos is to streamline the denial and collections process so providers can focus on what matters most – operating their practices and serving their patients,” said Michal Miernowski, CEO and Co-Founder of Amperos Health.
“The most recent funding round will be critical as Amperos accelerates its growth to serve more providers, expands its analytics capabilities, and launches new agentic capabilities in other RCM workflows,” added Michal Miernowski.
Digital health companies, including denial management and revenue cycle management startups, have secured more than $180 billion in funding to date, according to our recent Funding Database.
AI-driven digital health startups have led funding activity in 2026, attracting the largest share of capital so far this year.
Notable recent funding rounds include:
- Ethermed, a healthcare technology startup building AI-driven automation for prior authorization and medical-necessity workflows, raised $8.5 million in Series A funding to expand its enterprise platform and scale its growing network of health-system partners.
- Joyful Health, a provider of AI financial infrastructure for healthcare revenue operations, raised $17 million in Series A funding to build a financial operating system for healthcare providers.
- Luminai, a provider of an AI-powered healthcare workflow automation platform, raised $38 million in a Series B funding round, bringing its total funding to date to $60 million.
- Click Therapeutics, a developer of AI-based digital therapeutics, raised $50 million in Series D funding from Boehringer Ingelheim to support the commercialization of its CT-155, an investigational prescription digital therapeutic that is being studied for the treatment of the experiential negative symptoms of schizophrenia in adults aged 18 years and older.